cancers

Pfizer aims to increase market share, will sell patented drugs and vaccines at low prices for low income countries

By admin1 on May 25, 2022 • ( 0 )

On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›

Bristol-Myers Squibb Co and Eisai Co to jointly develop, market experimental cancer drug

By admin1 on June 18, 2021 • ( 0 )

In a statement, Bristol-Myers Squibb Co and Eisai Co said, they had entered into an agreement to jointly develop and market an experimental cancer drug worth up to $3.10 billion. Bristol-Myers would pay $650 million, including for research and development… Read More ›